Kiltearn Partners LLP Has $45.08 Million Stock Position in CVS Health Co. (NYSE:CVS)

Kiltearn Partners LLP reduced its holdings in CVS Health Co. (NYSE:CVS) by 9.4% during the third quarter, Holdings Channel.com reports. The fund owned 716,868 shares of the pharmacy operator’s stock after selling 74,800 shares during the quarter. CVS Health accounts for 6.1% of Kiltearn Partners LLP’s investment portfolio, making the stock its 3rd largest holding. Kiltearn Partners LLP’s holdings in CVS Health were worth $45,077,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health in the third quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the third quarter valued at about $32,000. First Community Trust NA increased its holdings in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares during the period. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health during the 3rd quarter valued at about $33,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of analyst reports. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Mizuho lowered their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Barclays cut their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Piper Sandler cut their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $70.33.

CVS Health Price Performance

NYSE CVS opened at $59.02 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $74.27 billion, a P/E ratio of 14.98, a PEG ratio of 1.01 and a beta of 0.55. The company has a 50-day moving average price of $59.26 and a 200-day moving average price of $58.69. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm earned $2.21 earnings per share. Equities research analysts anticipate that CVS Health Co. will post 5.43 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.51%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.